Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Viral Hepatitis

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2893.2005.00511.xPMID 15850465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased Frequency of the HLA-DRB1*11 Allele in Patients with Chronic Hepatitis C Virus Infection

  2002cited by this paper
• Intrahepatic and circulating HLA class II–restricted, hepatitis C virus–specific T cells: Functional characterization in patients with chronic hepatitis C

  2002cited by this paper
• Changes in hypervariable region 1 in patients with chronic hepatitis C of genotype 1b with biochemical response to interferon.

  2002cited by this paper
• Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase

  2002cited by this paper
• Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels

  2002cited by this paper
• HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

  2002cited by this paper
• [Molecular virology of hepatitis C].

  2002cited by this paper
• Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor.

  2001cited by this paper
• Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients

  2001cited by this paper
• HLA class II genes determine the natural variance of hepatitis C viral load

  2001cited by this paper
• Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A*

  2001cited by this paper
• Viral, host and interferon‐related factors modulating the effect of interferon therapy for hepatitis C virus infection

  2001cited by this paper
• Hepatitis C virus replication in mice with chimeric human livers

  2001cited by this paper
• Identification of immunodominant hepatitis C virus (HCV)‐specific cytotoxic T‐cell epitopes by stimulation with endogenously synthesized HCV antigens

  2001cited by this paper
• Long‐term follow‐up study of sustained biochemical responders with interferon therapy

  2001cited by this paper
• Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection.

  2001cited by this paper
• Hepatitis C virus and its pathogenesis.

  2000cited by this paper
• Characteristics of hepatitis C viral genome associated with disease progression

  2000cited by this paper
• Clinical significance of hepatitis C virus genotypes and quasispecies.

  2000cited by this paper
• Apoptosis and pathogenesis of viral hepatitis C--an update.

  2000cited by this paper
• Efficient initiation of HCV RNA replication in cell culture.

  2000cited by this paper
• Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long‐term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis

  1999cited by this paper
• Quasispecies in viral persistence and pathogenesis of hepatitis C virus.

  1999cited by this paper
• Mutations in nonstructural protein 5A gene and response to interferon in hepatitis C virus genotype 2 infection

  1999cited by this paper
• NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.

  1999cited by this paper
• Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line

  1999cited by this paper
• Evolution of the hypervariable region of hepatitis C virus

  1999cited by this paper
• Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

  1999cited by this paper
• Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.

  1999cited by this paper
• Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis

  1998cited by this paper
• Hepatitis C virus infection: virus/host interactions

  1998cited by this paper
• Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation

  1998cited by this paper
• The treatment of chronic viral hepatitis.

  1997cited by this paper
• The molecular virology of hepatitis C

  1997cited by this paper
• Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes

  1997cited by this paper
• Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

  1996cited by this paper
• Structure of the 3' terminus of the hepatitis C virus genome

  1996cited by this paper
• Report of the Japanese Central Bone Marrow Data Center.

  1996cited by this paper
• HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.

  1995cited by this paper
• Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.

  1995cited by this paper
• Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation

  1995cited by this paper
• The hepatitis C virus NS3 serine proteinase and NS4A cofactor: establishment of a cell-free trans-processing assay.

  1995cited by this paper
• CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.

  1995cited by this paper
• A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro

  1995cited by this paper
• Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

  1995cited by this paper
• Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.

  1995cited by this paper
• A proposed system for the nomenclature of hepatitis C viral genotypes

  1994cited by this paper
• Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins

  1994cited by this paper
• Treatment of chronic viral hepatitis.

  1994cited by this paper
• Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

  1993cited by this paper
• Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo.

  1993cited by this paper
• Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

  1993cited by this paper
• T-lymphocyte response to hepatitis C virus in different clinical courses of infection.

  1993cited by this paper
• Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

  1992cited by this paper
• Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis.

  1992cited by this paper
• Typing of hepatitis C virus genomes by restriction fragment length polymorphism.

  1991cited by this paper
• Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

  1990cited by this paper
• Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

  1989cited by this paper
• [Non-A, non-B viral hepatitis].

  1985cited by this paper

• In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6

  2019cites this paper
• HLA-KIR Interactions and Immunity to Viral Infections

  2014influential citation
• An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants.

  2013cites this paper
• An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region

  2012cites this paper
• Pharmacogenetic Issues in Biopharmaceutical Drug Development

  2008cites this paper
• Taxonomy of genus Hepacivirus. Application of palindromic nucleotide substitutions for the determination of genotypes of human hepatitis C virus species.

  2008cites this paper
• The Emerging Role of Pharmacogenomics in Biologics

  2007cites this paper
• Emergence of occult minority genotype 2b hepatitis C infection in an HIV-1-co-infected patient treated for genotype 5a HCV infection with 48 weeks of pegylated-interferon-alpha 2b and ribavirin.

  2007cites this paper
• Viral load change and sequential evolution of entire hepatitis C virus genome in Irish recipients of single source‐contaminated anti‐D immunoglobulin *

  2005cites this paper
• Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha.

  2004cites this paper